ZA202210143B - Use of linc01978 inhibitor in preparation of medicament for treating colorectal cancer - Google Patents

Use of linc01978 inhibitor in preparation of medicament for treating colorectal cancer

Info

Publication number
ZA202210143B
ZA202210143B ZA2022/10143A ZA202210143A ZA202210143B ZA 202210143 B ZA202210143 B ZA 202210143B ZA 2022/10143 A ZA2022/10143 A ZA 2022/10143A ZA 202210143 A ZA202210143 A ZA 202210143A ZA 202210143 B ZA202210143 B ZA 202210143B
Authority
ZA
South Africa
Prior art keywords
linc01978
medicament
inhibitor
preparation
colorectal cancer
Prior art date
Application number
ZA2022/10143A
Inventor
Yining Zhao
Xueren Gao
Original Assignee
Univ Yancheng Teachers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yancheng Teachers filed Critical Univ Yancheng Teachers
Publication of ZA202210143B publication Critical patent/ZA202210143B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA2022/10143A 2022-08-08 2022-09-13 Use of linc01978 inhibitor in preparation of medicament for treating colorectal cancer ZA202210143B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210941154.5A CN116570714A (en) 2022-08-08 2022-08-08 Application of LINC01978 inhibitor in preparation of colorectal cancer treatment drug

Publications (1)

Publication Number Publication Date
ZA202210143B true ZA202210143B (en) 2022-12-21

Family

ID=84602834

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/10143A ZA202210143B (en) 2022-08-08 2022-09-13 Use of linc01978 inhibitor in preparation of medicament for treating colorectal cancer

Country Status (2)

Country Link
CN (1) CN116570714A (en)
ZA (1) ZA202210143B (en)

Also Published As

Publication number Publication date
CN116570714A (en) 2023-08-11

Similar Documents

Publication Publication Date Title
EP4062914A4 (en) Use of fak inhibitor in preparation of drug for treating tumors having nras mutation
IL288395A (en) Heterobicyclic inhibitors of mat2a and methods of use for treating cancer
EP4008338A4 (en) Use of fgf21 in preparation of medicine for treating colorectal cancer
NZ602084A (en) Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers
IL284324A (en) Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer
IL284326A (en) Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer
EP4119156A4 (en) Medicament for treatment and/or prevention of cancer
IL304294A (en) Pharmaceutical combinations of sos1 inhibitors for treating and/or preventing cancer
IL289787A (en) Antibody combinations for treatment of cancer in specific patients
IL292143A (en) Alkylesters of alpha-methyl-dl-tyrosine for use in treating cancer
WO2015035410A8 (en) Cancer therapy
IL288787A (en) Methods and compositions for improving outcomes of cancer patients
IL285050A (en) Administration of pd-1 inhibitors for treating skin cancer
EP4110822A4 (en) Compositions and methods for treating cancer
EP4127722A4 (en) Methods and compositions for treating cancer
ZA202210143B (en) Use of linc01978 inhibitor in preparation of medicament for treating colorectal cancer
IL308992A (en) Treatment of cancer in patients with soluble fr-alpha
IL308058A (en) Molephantin derivatives useful in the treatment of cancer
EP4114864A4 (en) Compositions and methods for treatment of cancer
ZA202205628B (en) Use of nupr1 inhibitor in preparation of drugs for treating bladder cancer
EP4101464A4 (en) Use of anti-pd-1 antibody in treatment of malignant tumors
EP4119158A4 (en) Medicament for treatment and/or prevention of cancer
EP4119160A4 (en) Medicament for treatment and/or prevention of cancer
EP4119159A4 (en) Medicament for treatment and/or prevention of cancer
EP4119157A4 (en) Medicament for treatment and/or prevention of cancer